Skip to main content

Advertisement

Log in

Guidelines for the Management of Depression During Pregnancy

  • INVITED COMMENTARY
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Guidelines regarding the treatment of depression during pregnancy were recently published by the American Psychiatric Association and the American College of Obstetricians and Gynecologists. We provide a commentary on these guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Yonkers KA, Wisner KL, Stewart DE, et al.: The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 2009, 114:703–713.

    Article  PubMed  Google Scholar 

  2. Yonkers KA, Wisner KL, Stewart DE, et al.: The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 2009, 31:403–413.

    Article  PubMed  Google Scholar 

  3. Tanne JH: GlaxoSmithKline told to pay family $2.5 m after jury finds paroxetine caused son’s heart defects. BMJ 2009, 339:b4266.

    Article  PubMed  Google Scholar 

  4. Gaynes BN, Gavin N, Meltzer-Brody S, et al.: Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005, 119:1–8.

    Google Scholar 

  5. O’Connor EA, Whitlock EP, Beil TL, Gaynes BN: Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009, 151:793–803.

    PubMed  Google Scholar 

  6. U.S. Preventive Services Task Force: Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 2009, 151:784–792.

    Google Scholar 

  7. Dimidjian S, Goodman S: Nonpharmacologic intervention and prevention strategies for depression during pregnancy and the postpartum. Clin Obstet Gynecol 2009, 52:498–515.

    Article  PubMed  Google Scholar 

  8. O’Mahen HA, Flynn HA: Preferences and perceived barriers to treatment for depression during the perinatal period. J Womens Health (Larchmt) 2008, 17:1301–1309.

    Article  Google Scholar 

  9. Kim DR, Gonzalez J, O’Reardon JP: Pregnancy and depression: exploring a new potential treatment option. Curr Psychiatry Rep 2009, 11:443–446.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Dr. Kim has been lent a device for research purposes by and received a travel stipend from Neuronetics.

Dr. O’Reardon has received grant research support from AstraZeneca, Bristol-Myers Squibb, CeneRx Biopharma, Cyberonics, Eli Lilly and Company, the Magstim Company, Medtronic, Neuronetics, Pfizer, Sanofi-Aventis, and the NARSAD Foundation; has served as a consultant for Eli Lilly and Company; and is a member of the speakers’ bureau for Eli Lilly and Company and Bristol-Myers Squibb.

Dr. Epperson has served as a consultant for Wyeth and owns stock in Johnson & Johnson.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deborah R. Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, D.R., O’Reardon, J.P. & Epperson, C.N. Guidelines for the Management of Depression During Pregnancy. Curr Psychiatry Rep 12, 279–281 (2010). https://doi.org/10.1007/s11920-010-0114-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-010-0114-x

Keywords

Navigation